Jeremy Roberts

1.7k total citations
20 papers, 1.2k citations indexed

About

Jeremy Roberts is a scholar working on Infectious Diseases, Virology and Psychiatry and Mental health. According to data from OpenAlex, Jeremy Roberts has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Psychiatry and Mental health. Recurrent topics in Jeremy Roberts's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Respiratory and Cough-Related Research (3 papers). Jeremy Roberts is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Respiratory and Cough-Related Research (3 papers). Jeremy Roberts collaborates with scholars based in United States, Canada and United Kingdom. Jeremy Roberts's co-authors include Elizabeth F. Juniper, Penelope J. Ferrie, Ann Thompson, Paul M. O’Byrne, Derek King, Fred M. Cox, Geoff Norman, Per Hildebrandt, Günter A.J. Riegger and Stephen McMorn and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jeremy Roberts

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeremy Roberts United States	14	601	362	283	143	115	20	1.2k
G. Duru France	16	386 0.6×	67 0.2×	248 0.9×	49 0.3×	131 1.1×	43	1.3k
J O Warner United Kingdom	19	718 1.2×	321 0.9×	568 2.0×	65 0.5×	109 0.9×	31	1.2k
Tim Harrison United Kingdom	27	1.6k 2.7×	224 0.6×	1.5k 5.3×	47 0.3×	21 0.2×	70	2.2k
Stanley Goldstein United States	17	396 0.7×	215 0.6×	286 1.0×	10 0.1×	75 0.7×	57	900
Thomas Glaab Germany	23	1.2k 2.0×	104 0.3×	1.4k 5.1×	31 0.2×	16 0.1×	50	2.1k
T Kava Finland	16	2.5k 4.1×	389 1.1×	2.0k 7.2×	32 0.2×	42 0.4×	20	3.0k
Sabrina Di Pillo Italy	15	324 0.5×	111 0.3×	295 1.0×	58 0.4×	76 0.7×	61	731
Ubong Peters United States	10	763 1.3×	46 0.1×	607 2.1×	45 0.3×	16 0.1×	21	1.4k
E. Helen Ramsdale Canada	15	1.6k 2.6×	358 1.0×	1.4k 5.0×	20 0.1×	53 0.5×	24	1.9k
Maria Watson United States	11	532 0.9×	93 0.3×	448 1.6×	24 0.2×	33 0.3×	17	1.1k

Countries citing papers authored by Jeremy Roberts

Since Specialization

Citations

This map shows the geographic impact of Jeremy Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Roberts more than expected).

Fields of papers citing papers by Jeremy Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Roberts. The network helps show where Jeremy Roberts may publish in the future.

Co-authorship network of co-authors of Jeremy Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Roberts. A scholar is included among the top collaborators of Jeremy Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Roberts. Jeremy Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamerson, Brenda D., et al.. (2025). Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression. Psychopharmacology Bulletin. 37(2). 67–78.

Polli, Joseph W., Parul Patel, Richard Grove, et al.. (2023). Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials. The Journal of Infectious Diseases. 230(1). e34–e42. 10 indexed citations

Patel, Parul, Ronald D’Amico, Conor Smith, et al.. (2022). 1586. Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations

Mills, Anthony, Gary Richmond, Cheryl Newman, et al.. (2021). Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy. AIDS. 36(2). 195–203. 25 indexed citations

Mills, Anthony, Gary Richmond, Cheryl Newman, et al.. (2020). 116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study. Open Forum Infectious Diseases. 7(Supplement_1). S186–S187. 1 indexed citations

Quercia, Romina, et al.. (2015). Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks. Clinical Drug Investigation. 35(3). 211–219. 66 indexed citations

Graham, Barney S., Rhonda C. Kines, Kizzmekia S. Corbett, et al.. (2010). Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunology. 3(5). 475–486. 23 indexed citations

Rosenberg, Matt T., et al.. (2008). Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study. International Journal of Clinical Practice. 63(1). 27–34. 17 indexed citations

Graham, Jay A., et al.. (2007). Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.. PubMed. 9(2). 41–41. 7 indexed citations

10.

Kaye, Neil, Jay A. Graham, Jeremy Roberts, Thomas R. Thompson, & Kevin P. Nanry. (2007). Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Scores of Patients With Bipolar I Disorder. Journal of Clinical Psychopharmacology. 27(4). 387–391. 12 indexed citations

11.

Dargie, Henry J., Per Hildebrandt, Günter A.J. Riegger, et al.. (2007). A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure. Journal of the American College of Cardiology. 49(16). 1696–1704. 153 indexed citations

12.

Ketter, Terence A., John H. Greist, James A. Graham, et al.. (2006). The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder. The Journal of Clinical Psychiatry. 67(3). 400–406. 19 indexed citations

13.

Kemp, Graham J., Qiyong Gong, William E. Bimson, et al.. (2004). Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo. Nephrology Dialysis Transplantation. 19(6). 1520–1527. 59 indexed citations

14.

Juniper, Elizabeth F., Ann Thompson, & Jeremy Roberts. (2002). Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF‐36. Allergy. 57(3). 201–206. 51 indexed citations

15.

Juniper, Elizabeth F., Geoff Norman, Fred M. Cox, & Jeremy Roberts. (2001). Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. European Respiratory Journal. 18(1). 38–44. 78 indexed citations

16.

Juniper, Elizabeth F., Paul M. O’Byrne, & Jeremy Roberts. (2001). Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use?. Respiratory Medicine. 95(5). 319–323. 101 indexed citations

17.

Juniper, Elizabeth F., Paul M. O’Byrne, Penelope J. Ferrie, Derek King, & Jeremy Roberts. (2000). Measuring Asthma Control. American Journal of Respiratory and Critical Care Medicine. 162(4). 1330–1334. 190 indexed citations

18.

Juniper, Elizabeth F., Ann Thompson, Penelope J. Ferrie, & Jeremy Roberts. (1999). Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire☆☆☆★. Journal of Allergy and Clinical Immunology. 104(2). 364–369. 305 indexed citations

19.

Xu, Guorong, Gerald Salen, Sarah Shefer, et al.. (1998). Regulation of classic and alternative bile acid synthesis in hypercholesterolemic rabbits: effects of cholesterol feeding and bile acid depletion. Journal of Lipid Research. 39(8). 1608–1615. 26 indexed citations

20.

Greenwood, Richard, A K Bhalla, Alan Gordon, & Jeremy Roberts. (1983). Behaviour disturbances during recovery from herpes simplex encephalitis.. Journal of Neurology Neurosurgery & Psychiatry. 46(9). 809–817. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact